CLINICAL PHARMACOKINETICS OF ALLOPURINOL

被引：116

作者：

MURRELL, GAC ^{[1
]}

RAPEPORT, WG ^{[1
]}

机构：

[1] UNIV OXFORD,DEPT CLIN PHARMACOL,MRC UNIT,OXFORD,ENGLAND

来源：

CLINICAL PHARMACOKINETICS | 1986年 / 11卷 / 05期

关键词：

D O I：

10.2165/00003088-198611050-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：343 / 353

页数：11

共 38 条

[1]

APPELBAUM SJ, 1982, CANC CHEMOTHER PHARM, V14, P789

[2]

BENEZRA SA, 1978, ANAL PROFILES DRUG S, V7, P1

[3] THE EFFECT OF DIETARY-PROTEIN ON THE CLEARANCE OF ALLOPURINOL AND OXYPURINOL [J].

BERLINGER, WG ;

PARK, GD ;

SPECTOR, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :771-776

[4] IDENTIFICATION OF HYPOXANTHINE TRANSPORT AND XANTHINE-OXIDASE ACTIVITY IN BRAIN CAPILLARIES [J].

BETZ, AL .

JOURNAL OF NEUROCHEMISTRY, 1985, 44 (02) :574-579

[5]

CASKEY CT, 1964, J BIOL CHEM, V239, P2570

[6] BIOAVAILABILITY OF ALLOPURINOL ORAL AND RECTAL DOSAGE FORMS [J].

CHANG, SL ;

KRAMER, WG ;

FELDMAN, S ;

BALLENTINE, R ;

FRANKEL, LS .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (03) :365-368

[7]

EDWARDS NL, 1981, J LAB CLIN MED, V98, P673

[8] RENAL CLEARANCE OF OXIPURINOL CHIEF METABOLITE OF ALLOPURINOL [J].

ELION, GB ;

YU, TF ;

GUTMAN, AB ;

HITCHINGS, GH .

AMERICAN JOURNAL OF MEDICINE, 1968, 45 (01) :69-+

[9]

ELION GB, 1966, BIOCHEM PHARMACOL, V15, P836

[10]

ELION GB, 1980, ADV EXPT BIOL MED, V1224, P263

← 1 2 3 4 →